TY - JOUR
T1 - An elderly patient with 17α-hydroxylase deficiency misdiagnosed as primary aldosteronism
T2 - a case report
AU - Ishinoda, Yuki
AU - Uto, Asuka
AU - Yamada, Yoshifumi
AU - Okazaki, Maki
AU - Asada, Hidetomo
AU - Wakamatsu, Seina
AU - Kurihara, Isao
AU - Shibata, Hironori
AU - Ishii, Tomohiro
AU - Hasegawa, Tomonobu
AU - Kumagai, Hiroo
AU - Kasuga, Akira
N1 - Funding Information:
We would like to thank the physicians, nurses, and technicians of the National Defense Medical College Hospital who were involved in the diagnosis and treatment of this case. We would also like to thank Editage (www.editage.com) for the English language editing.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: 17α-hydroxylase deficiency (17OHD) is a rare autosomal recessive disorder. Aldosterone levels are usually low in patients with 17OHD. However, among the approximately 150 cases of 17OHD reported to date, aldosterone levels were not low in all cases. Therefore, some 17OHD cases may have been misdiagnosed as primary aldosteronism (PA) cases. Often before puberty, 17OHD is diagnosed because of abnormal genital morphology and menstrual irregularities. However, we report a very rare case of 17OHD in an elderly patient with a high aldosterone/renin ratio (ARR) similar to that in PA. Case presentation: A 63-year-old Japanese woman was transferred to our medical facility for the evaluation of bilateral adrenal hypertrophy, which was incidentally discovered during an abdominal examination after cholecystectomy. The patient had hypokalemia and a high aldosterone/renin ratio. Her medical history included hypertension and right intracerebral capsular hemorrhage at the age of 30 years. Additional testing revealed low cortisol, high adrenocorticotropic hormone, and low testosterone and dehydroepiandrosterone sulfate, indicating congenital adrenal hyperplasia. Genetic analysis revealed a mutation in the CYP17A1 gene and a karyotype of 46, XY; hence, she was diagnosed with 17OHD. Conclusion: 17OHD can resemble PA. The combination of a high ARR and low cortisol level should trigger the consideration of 17OHD.
AB - Background: 17α-hydroxylase deficiency (17OHD) is a rare autosomal recessive disorder. Aldosterone levels are usually low in patients with 17OHD. However, among the approximately 150 cases of 17OHD reported to date, aldosterone levels were not low in all cases. Therefore, some 17OHD cases may have been misdiagnosed as primary aldosteronism (PA) cases. Often before puberty, 17OHD is diagnosed because of abnormal genital morphology and menstrual irregularities. However, we report a very rare case of 17OHD in an elderly patient with a high aldosterone/renin ratio (ARR) similar to that in PA. Case presentation: A 63-year-old Japanese woman was transferred to our medical facility for the evaluation of bilateral adrenal hypertrophy, which was incidentally discovered during an abdominal examination after cholecystectomy. The patient had hypokalemia and a high aldosterone/renin ratio. Her medical history included hypertension and right intracerebral capsular hemorrhage at the age of 30 years. Additional testing revealed low cortisol, high adrenocorticotropic hormone, and low testosterone and dehydroepiandrosterone sulfate, indicating congenital adrenal hyperplasia. Genetic analysis revealed a mutation in the CYP17A1 gene and a karyotype of 46, XY; hence, she was diagnosed with 17OHD. Conclusion: 17OHD can resemble PA. The combination of a high ARR and low cortisol level should trigger the consideration of 17OHD.
KW - 17-alpha-hydroxylase deficiency
KW - 46XY testicular disorders of sex development
KW - Adrenal insufficiency
KW - Aldosterone
KW - Case report
KW - Congenital adrenal hyperplasia
KW - Cortisol
KW - Hypertension
KW - Hypokalemia
UR - http://www.scopus.com/inward/record.url?scp=85143314462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143314462&partnerID=8YFLogxK
U2 - 10.1186/s12902-022-01216-y
DO - 10.1186/s12902-022-01216-y
M3 - Article
C2 - 36461073
AN - SCOPUS:85143314462
SN - 1472-6823
VL - 22
JO - BMC Endocrine Disorders
JF - BMC Endocrine Disorders
IS - 1
M1 - 300
ER -